Yellow header pointerTECVAYLI®, a bispecific antibody, is the first treatment of its kind designed to fight multiple myeloma

Father and daughter playing in treehouseFather and daughter playing in treehouse

TECVAYLI® works by helping your immune system locate the multiple myeloma cells in your body.

  • One side of TECVAYLI® binds to proteins called which are found on your T-cells. The other side binds to proteins called , which are found on multiple myeloma cells (as well as some healthy cells).
  • In doing so, TECVAYLI® is able to activate the T-cells in your immune system to destroy the multiple myeloma cells in the rest of your body.

TECVAYLI® is a kind of medicine called a , which means it attaches to 2 different cells.

Cartoon t-cell and multiple myeloma cellTECVAYLI® (teclistamab-cqyv) mechanism of action: T cell and multiple myeloma cell

By binding to BCMA and CD3, TECVAYLI® helps the immune system recognize the multiple myeloma cell and destroy it.

TECVAYLI® (teclistamab-cqyv), a bispecific antibodyTECVAYLI® (teclistamab-cqyv), a bispecific antibody

 

LEARN ABOUT RESULTS WITH TECVAYLI®

Register to stay up-to-date with important information about TECVAYLI®